Pharmacokinetics of antisense oligonucleotide drugs
This review covers the pharmacokinetic characteristics of the various antisense oligonucleotide drugs. A comparison of the pharmacokinetics of drugs first and second generation. As well as the influence on the pharmacokinetics of the chemical modification of the molecule.
Saved in:
Main Authors: | M. R. Khaitov (Author), V. V. Smirnov (Author) |
---|---|
Format: | Book |
Published: |
LLC "Publisher OKI",
2013-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tissue pharmacokinetics of antisense oligonucleotides
by: Erica Bäckström, et al.
Published: (2024) -
Pharmacokinetic Studies of Antisense Oligonucleotides Using MALDI-TOF Mass Spectrometry
by: Markus Herkt, et al.
Published: (2020) -
Deep learning facilitates efficient optimization of antisense oligonucleotide drugs
by: Shenggeng Lin, et al.
Published: (2024) -
Antisense Oligonucleotides: Concepts and Pharmaceutical Applications
by: Ariana Araya, et al.
Published: (2023) -
Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol
by: Tomoko Nishina, et al.
Published: (2015)